한미약품, 2030년 매출 2조9000억 목표…비만치료제·신약 중심 4개 부문 체제로 전환
(서울=NSP통신) jeong seop park Jour = The Ministry of Food and Drug Safety(MFDS) is likely to approve the Corona19 Vaccine deveoped by SK Bioscience by the end of May, according to sources.
SK Bioscience(302440) has submitted documents to the MFDS to get approval for its corona19 vaccine, GBP510, on May 1.
NSP News Agency jeong seop park Journalist desk@nspna.com
Copyright ⓒ Korea's economic news agency NSP NEWS·NSP TV. All rights reserved-Redistribution Prohibited.